Senate Committee Approves Bill on Compounding A Senate committee approved a bill on Wednesday that would give the Food and Drug Administration greater authority over compounding pharmacies. The practice of compounding, the specialty mixing of medication for individual patients, drew national attention last fall when tainted products from a compounding pharmacy in Massachusetts caused a fungal meningitis outbreak that killed more than 50 people. Congressional staffers said the Senate would most likely consider the bill in July.